CVE-2013-0078
CVE-2013-0078 is a high-severity vulnerability in Microsoft Windows Defender with a CVSS 2.0 base score of 7.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-20.
Key facts
- Severity: High (CVSS 2.0 base score 7.2)
- EPSS exploit prediction: 2% (77th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-20
- Affected product: Microsoft Windows Defender
- Published:
- Last modified:
Description
The Microsoft Antimalware Client in Windows Defender on Windows 8 and Windows RT uses an incorrect pathname for MsMpEng.exe, which allows local users to gain privileges via a crafted application, aka "Microsoft Antimalware Improper Pathname Vulnerability."
Frequently asked questions
- What is CVE-2013-0078?
- The Microsoft Antimalware Client in Windows Defender on Windows 8 and Windows RT uses an incorrect pathname for MsMpEng.exe, which allows local users to gain privileges via a crafted application, aka "Microsoft Antimalware Improper Pathname Vulnerability."
- How severe is CVE-2013-0078?
- CVE-2013-0078 has a CVSS 2.0 base score of 7.2, rated high severity.
- Is CVE-2013-0078 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (77th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2013-0078?
- CVE-2013-0078 affects Microsoft Windows Defender. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2013-0078?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2013-0078 published?
- CVE-2013-0078 was published on 2013-04-09 and last updated on 2026-06-16.
References
- http://www.us-cert.gov/ncas/alerts/TA13-100A
- https://docs.microsoft.com/en-us/security-updates/securitybulletins/2013/ms13-034
- https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A16293
Affected products (1)
- cpe:2.3:a:microsoft:windows_defender:*:*:*:*:*:*:*:*
More vulnerabilities in Microsoft Windows Defender
- CVE-2006-5270 — Critical (CVSS 9.3): Integer overflow in the Microsoft Malware Protection Engine (mpengine.dll), as used by Windows Live OneCare, Antigen,…
- CVE-2018-0986 — High (CVSS 8.8): A remote code execution vulnerability exists when the Microsoft Malware Protection Engine does not properly scan a…
- CVE-2023-36422 — High (CVSS 7.8): Microsoft Windows Defender Elevation of Privilege Vulnerability
- CVE-2023-38175 — High (CVSS 7.8): Microsoft Windows Defender Elevation of Privilege Vulnerability
- CVE-2021-24092 — High (CVSS 7.8): Microsoft Defender Elevation of Privilege Vulnerability
- CVE-2021-1647 — High (CVSS 7.8): Microsoft Defender Remote Code Execution Vulnerability
All CVEs affecting Microsoft Windows Defender →
Other CWE-20 (Improper Input Validation) vulnerabilities
- CVE-2026-48056 — Critical (CVSS 10.0): Streambert is a cross-platform Electron Desktop App to stream and download video content. Versions prior to 2.5.0…
- CVE-2026-33267 — Critical (CVSS 10.0): Improper Input Validation vulnerability in Apache Traffic Server. This issue affects Apache Traffic Server: from 9.2.0…
- CVE-2026-47668 — Critical (CVSS 10.0): DbGate is cross-platform database manager. In versions 7.1.8 and prior, DbGate's JSON script runner (`POST…
- CVE-2026-16117 — Critical (CVSS 10.0): Impact: @fastify/http-proxy versions up to and including 11.5.0 fail to rewrite the request prefix when the prefix…
- CVE-2026-48316 — Critical (CVSS 10.0): ColdFusion versions 2025.9, 2023.20 and earlier are affected by an Improper Input Validation vulnerability that could…
- CVE-2026-48281 — Critical (CVSS 10.0): ColdFusion versions 2025.9, 2023.20 and earlier are affected by an Improper Input Validation vulnerability that could…
Browse all CWE-20 (Improper Input Validation) vulnerabilities →